-
Mashup Score: 2Risk Score Helps Identify Patients With CH at High Risk of Myeloid Malignancy | ASH Clinical News | American Society of Hematology - 8 month(s) ago
Anna Azvolinsky, PhD, is a freelance medical and science journalist based in New York City. Clonal hematopoiesis (CH) is relatively common, with up to 15% of adults age 60 and older estimated to have one of two CH conditions: CH of indeterminate potential (CHIP) and clonal cytopenia of undetermined significance (CCUS). The rate of diagnosis of these two conditions is steadily increasing. CH is associated with an increased risk of developing myeloid blood cancers but, for most patients, this risk is
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Endocrine Society Publishes First Hypercalcemia of Malignancy Guideline - Endocrine News - 1 year(s) ago
A new Endocrine Society guideline details how to treat adult patients with hypercalcemia of malignancy, the most common metabolic cancer complication. Despite its high morbidity and mortality rates, this is the very first guideline that directly addresses this condition and confirms the efficacy of denosumab and bisphosphonates. Adults with hypercalcemia of malignancy should be treated…
Source: Endocrine NewsCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 1Research in Brief - 1 year(s) ago
The humanised anti-IL-17A and IL-17F monoclonal antibody bimekizumab might be a safe and effective treatment option for patients with psoriatic arthritis who have either never received biological disease-modifying antirheumatic drugs (DMARDs) or who have had a previous inadequate response or intolerance to tumour necrosis factor (TNF) inhibitors, according to two multicentre, phase 3,…
Source: The Lancet RheumatologyCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Diagnosis of thyroid nodules - 1 year(s) ago
Thyroid nodules are common, usually asymptomatic, and often pose minimal risk to the affected patient. However, 10–15% prove malignant and serve as the rationale for diagnostic assessment. Safely identifying and treating a relevant thyroid cancer through a cost-effective process is the primary goal of the treating practitioner. Ultrasound is the principal means of initial nodule assessment and…
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 1Adjuvant Treatment for Merkel Cell Carcinoma - 1 year(s) ago
Merkel cell carcinoma is a rare, aggressive cutaneous malignancy that originates due to the uncontrollable proliferation of Merkel cells.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0The association between nutritional risk index and ICU outcomes across hematologic malignancy patients with acute respiratory failure - PubMed - 1 year(s) ago
Patients with hematological malignancies (HM) are at risk of acute respiratory failure (ARF). Malnutrition, a common association with HM, has the potential to influence ICU outcomes. Geriatric nutritional risk index (G-NRI) is a score derived from albumin and weight, which reflects risk of protein-e …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial - 1 year(s) ago
The antifibrinolytic agent tranexamic acid (TXA) is often used to prevent bleeding in patients with hemorrhagic disorders or platelet dysfunction, and there has
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Key Points. After a median of 10.0 years of follow-up, low-count MBL had a significant 4.3-fold increased risk of lymphoid malignancies.After a median of 34.4 m
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Diagnosis of thyroid nodules - 1 year(s) ago
Thyroid nodules are common, usually asymptomatic, and often pose minimal risk to the affected patient. However, 10–15% prove malignant and serve as the rationale for diagnostic assessment. Safely identifying and treating a relevant thyroid cancer through a cost-effective process is the primary goal of the treating practitioner. Ultrasound is the principal means of initial nodule assessment and…
Categories: Endocrinology, Latest HeadlinesTweet
Using whole-exome sequencing data, researchers have developed a risk score that estimates a patient’s risk of progression from CHIP or CCUS to a #myeloid #malignancy and identifies patients at high risk for #clonalhematopoiesis https://t.co/KgLn3e5IKU